Late breast metastasis from resected lung cancer diagnosed by epidermal growth factor receptor gene mutationFUKUMOTO, Koichi; USAMI, Noriyasu; OKASAKA, Toshiki et al.Lung cancer. 2011, Vol 74, Num 2, pp 352-353, issn 0169-5002, 2 p.Article

Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: A case report and review of the literatureTOGASHI, Yosuke; MASAGO, Katsuhiro; HAMATANI, Yasuhiro et al.Lung cancer. 2012, Vol 77, Num 2, pp 464-468, issn 0169-5002, 5 p.Article

Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancerTOGASHI, Yosuke; MASAGO, Katsuhiro; MISHIMA, Michiaki et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 3, pp 399-405, issn 0344-5704, 7 p.Article

The characterization of gefitinib sensitivity and adverse events in patients with non-small cell lung cancerKOYAMA, Nobuyuki; JINN, Yasuto; TAKABE, Kazuhiko et al.Anticancer research. 2006, Vol 26, Num 6B, pp 4519-4525, issn 0250-7005, 7 p.Article

Association of Diffuse, Random Pulmonary Metastases, Including Miliary Metastases, With Epidermal Growth Factor Receptor Mutations in Lung AdenocarcinomaTOGASHI, Yosuke; MASAGO, Katsuhiro; KUBO, Takeshi et al.Cancer. 2011, Vol 117, Num 4, pp 819-825, issn 0008-543X, 7 p.Article

Serum Carcinoembryonic Antigen Level Is Associated With Epidermal Growth Factor Receptor Mutations in Recurrent Lung AdenocarcinomasSHOJI, Fumihiro; YOSHINO, Ichiro; YANO, Tokujiro et al.Cancer. 2007, Vol 110, Num 12, pp 2793-2798, issn 0008-543X, 6 p.Article